Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.290
+0.220 (10.63%)
At close: Nov 22, 2024, 4:00 PM
2.270
-0.020 (-0.87%)
After-hours: Nov 22, 2024, 7:02 PM EST
Fate Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Hold
Price Target
$6.75
Upside
+194.76%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 19, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +118.34% | Aug 22, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 14, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $4 → $6 | Hold → Buy | Upgrades | $4 → $6 | +162.01% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +118.34% | May 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +293.01% | May 10, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +162.01% | May 10, 2024 |
| Wedbush | Wedbush | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +118.34% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $7 → $4 | Hold | Maintains | $7 → $4 | +74.67% | May 10, 2024 |
| Wedbush | Wedbush | Hold Reiterates $7 | Hold | Reiterates | $7 | +205.68% | May 6, 2024 |
| Wedbush | Wedbush | Hold Reiterates $7 | Hold | Reiterates | $7 | +205.68% | Apr 23, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 11, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $2 → $6 | Sell | Maintains | $2 → $6 | +162.01% | Mar 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +205.68% | Mar 19, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $3 → $7 | Hold | Maintains | $3 → $7 | +205.68% | Feb 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.